Who is sponsoring NCT04152798?

NCT04152798 is sponsored by Grubnik Volodymyr.

What drugs are being tested in NCT04152798?

Interventions in NCT04152798: Laparoscopic hiatal hernia repair with ProGrip™ mesh, Laparoscopic primary posterior crural repair.

What condition does NCT04152798 study?

NCT04152798 studies Hiatal Hernia, Gastroesophageal Reflux Disease.

Is NCT04152798 still recruiting?

NCT04152798 is currently completed. Last updated 7 November 2019.

Last reviewed 2019-11-07 · How we verify

NCT04152798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Approach to Hiatal Hernia Repair Based on Collagen Study

Completed NA Last updated 7 November 2019

What this trial tests

NA trial testing Laparoscopic hiatal hernia repair with ProGrip™ mesh in Hiatal Hernia in 140 participants. Completed in 20 September 2019.

Timeline

1 January 2014

Primary endpoint
20 September 2019

20 September 2019

Quick facts

Lead sponsor	Grubnik Volodymyr
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	140
Start date	1 January 2014
Primary completion	20 September 2019
Estimated completion	20 September 2019

Drugs / interventions tested

Laparoscopic hiatal hernia repair with ProGrip™ mesh
Laparoscopic primary posterior crural repair

Conditions studied

Hiatal Hernia — all drugs for Hiatal Hernia →
Gastroesophageal Reflux Disease — all drugs for Gastroesophageal Reflux Disease →

Sponsor

Grubnik Volodymyr

Who can join

Adults 20 to 80, any sex, with Hiatal Hernia or Gastroesophageal Reflux Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Groups of patients who underwent laparoscopic repair of large hiatal hernias by primary posterior crural repair and crural repair with ProGrip™ mesh techniques were examined for recurrence rate of hiatal hernias, quality of life according to the GERD-HRQL questionnaire. Clinical evaluation was performed at 3, 6, 12, 24, 36, and 48 months after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hiatal Hernia

Currently open trials in the same condition.

NCT07070115 — Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® · NA · recruiting
NCT06725433 — Nissen Versus Dor Hiatal Hernia Repair · NA · recruiting
NCT06884800 — Laparoscopic Toupet's Fundoplication: Is it Proper Solution of Radiological Negative, Endoscopically Positive Hiatal Her · NA · recruiting
NCT05953428 — Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia · NA · recruiting
NCT05201508 — Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair · NA · recruiting

Other Grubnik Volodymyr trials

Trials by the same sponsor.

NCT04335734 — Influence of Wrap Fixation Technique on the Results of Fundoplication · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04152798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Grubnik Volodymyr
Last refreshed: 7 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04152798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing